Chinese GPU Maker Sees Shipments Surge but Posts 2025 Loss of ¥781m

MuXi reported ¥1.644 billion in 2025 revenue, up 121% year‑on‑year, driven by a notable rise in GPU shipments, but still posted a ¥781 million net loss. The results signal strong market acceptance of the company's GPUs while underscoring the persistent profitability and cash‑burn challenges facing China’s emerging AI‑chip vendors.

Three NVIDIA GeForce RTX graphics cards stacked on a surface, showcasing their sleek design and branding details.

Key Takeaways

  • 1MuXi's 2025 revenue rose 121.26% to ¥1.644 billion, driven by significantly higher GPU shipments.
  • 2The company reported a net loss attributable to the parent of ¥781 million for 2025 despite the revenue surge.
  • 3Increased customer adoption suggests product-market fit, but scale has not yet yielded positive operating leverage.
  • 4The results reflect broader dynamics in China’s domestic GPU sector: rising demand but intense competition and margin pressure.
  • 5Key metrics to watch: gross margin trends, cash burn, order backlog, and progress converting pilot orders into long‑term contracts.

Editor's
Desk

Strategic Analysis

MuXi’s figures typify the current phase of China’s chip ecosystem: fast growth in units and revenue as AI workloads proliferate, paired with volatile profitability while firms invest in product maturity, software stacks and production capacity. The strategic imperative for MuXi is to turn customer wins into larger, recurring revenue streams with higher margins—through differentiated performance, tighter vertical integration, or strategic partnerships with cloud providers. Failure to improve margins will leave the company exposed to intense price competition and financing risk, but a successful transition could make MuXi an important domestic supplier in an industry where governments and enterprises are eager to reduce reliance on foreign accelerators.

China Daily Brief Editorial
Strategic Insight
China Daily Brief

MuXi Technology (688802.SH) reported a striking dichotomy in its 2025 preliminary results: revenue more than doubled to ¥1.644 billion while the company recorded a net loss attributable to the parent of ¥781 million. The company said accelerated customer adoption and repeat purchases drove a “significant” rise in GPU product shipments, which powered the large year‑on‑year jump in sales.

The top‑line momentum illustrates growing demand for domestic accelerators as Chinese cloud and enterprise customers expand AI deployments. Yet the bottom line shows that scale alone has not translated into profitability: heavy R&D spending, capacity expansion, sales discounts to win customers, and one‑off accounting items are among the plausible explanations for the continued operating losses at ASIC and GPU startups in China.

MuXi’s results arrive against a broader industry backdrop in which Chinese GPU and AI‑chip vendors are racing to capture local market share after export controls and geopolitical frictions made domestic supply chains a strategic priority. Rival companies have shown mixed outcomes—some have posted rapid revenue growth while a handful have recently returned to profit—highlighting how uneven the route to sustainable margins remains.

For investors, the numbers present a familiar trade‑off: strong growth and customer traction versus persistent cash burn and uncertainty over when gross margins will improve. The company will need to demonstrate either higher average selling prices, lower manufacturing costs, or meaningful operating‑leverage gains to convince markets that revenues can convert into profits.

Strategically, MuXi’s shipment gains matter beyond one balance sheet. If the firm can convert trial and pilot orders into recurring, larger contracts with hyperscalers and industrial buyers, it could help diversify China’s GPU supply and reduce dependence on foreign incumbents. But that outcome depends on execution—product reliability, software ecosystem, supply‑chain resilience and the ability to finance continued expansion without diluting equity excessively.

Share Article

Related Articles

📰
No related articles found